SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-037367
Filing Date
2024-03-27
Accepted
2024-03-27 17:24:37
Documents
2
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5819
2 EX-24 qttb-ex24.htm EX-24 12715
  Complete submission text file 0000950170-24-037367.txt   20033
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Issuer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38433 | Film No.: 24792089